保龄宝：HMOs建设项目设计产能2500吨 预计下半年投产

Core Viewpoint - The company Baolingbao (002286) announced on August 7 that its HMO (Human Milk Oligosaccharides) construction project is designed to have a production capacity of 2,500 tons, with an expected operational start in the second half of 2025 [1] Group 1 - The HMO project is a significant investment in the production of human milk oligosaccharides, which are essential for infant nutrition [1] - The planned production capacity of 2,500 tons indicates a substantial scale of operations aimed at meeting market demand [1] - The timeline for production commencement in the second half of 2025 suggests a strategic long-term growth plan for the company [1]